MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617055850 A) filed by Design Therapeutics, Inc. on May 01, 2026, for Methods And Compounds For Modulating Huntington'S Disease.
Inventors include Nourie, Hannah; Sinha, Santosh; Waybright, Jarod; Yang, Fei; Zhang, Chengzhi; Convertino, Marino; and Yeh, Chien-Hung.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present disclosure relates to transcription modulator molecules having a first terminus, a second terminus, and an oligomeric backbone and methods for treating Huntington's disease (HD).
Disclaimer: Curated by HT Syndication.
